These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17214717)

  • 21. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts.
    Kubo K; Kuroyanagi Y
    J Artif Organs; 2003; 6(2):138-44. PubMed ID: 14598115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study.
    De Luca M; Albanese E; Cancedda R; Viacava A; Faggioni A; Zambruno G; Giannetti A
    Arch Dermatol; 1992 May; 128(5):633-8. PubMed ID: 1575526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective review of 20 hypertensive leg ulcers treated with mesh skin grafts.
    Dagregorio G; Guillet G
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):166-9. PubMed ID: 16441624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers.
    Yamada N; Uchinuma E; Kuroyanagi Y
    J Artif Organs; 2012 Jun; 15(2):193-9. PubMed ID: 22138722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous platelet-rich fibrin matrix as cell therapy in the healing of chronic lower-extremity ulcers.
    O'Connell SM; Impeduglia T; Hessler K; Wang XJ; Carroll RJ; Dardik H
    Wound Repair Regen; 2008; 16(6):749-56. PubMed ID: 19128245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test.
    Kubo K; Kuroyanagi Y
    J Artif Organs; 2003; 6(1):64-70. PubMed ID: 14598127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronic acid production and CD44 expression in cultured dermal fibroblasts of patients with non-insulin-dependent diabetes mellitus with and without chronic ulcers on the lower extremity.
    Yevdokimova NY; Podpryatov SE
    Wound Repair Regen; 2005; 13(2):181-8. PubMed ID: 15828943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-contact topical tretinoin therapy to stimulate granulation tissue in chronic wounds.
    Paquette D; Badiavas E; Falanga V
    J Am Acad Dermatol; 2001 Sep; 45(3):382-6. PubMed ID: 11511834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of a cryopreserved cultured dermal substitute composed of hyaluronic acid and collagen to release angiogenic cytokine.
    Sawa M; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2013; 24(2):224-38. PubMed ID: 23565599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers.
    Sibbald RG; Contreras-Ruiz J; Coutts P; Fierheller M; Rothman A; Woo K
    Adv Skin Wound Care; 2007 Oct; 20(10):549-58. PubMed ID: 17906429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Wound healing in venous ulcers; mechanisms, approach and modern developments].
    Gibbs S; van den Hoogenband HM; de Boer EM
    Ned Tijdschr Geneeskd; 2007 Mar; 151(11):635-40. PubMed ID: 17441566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of refractory, atypical lower extremity ulcers with tissue-engineered skin (Apligraf).
    Long RE; Falabella AF; Valencia I; Eaglstein WH; Kirsner RS
    Arch Dermatol; 2001 Dec; 137(12):1660-1. PubMed ID: 11735729
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of chronic leg ulcers with topical activated protein C.
    Whitmont K; Reid I; Tritton S; March L; Xue M; Lee M; Fulcher G; Sambrook P; Slobedman E; Cooper A; Jackson C
    Arch Dermatol; 2008 Nov; 144(11):1479-83. PubMed ID: 19015423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of ischemic wounds with noncontact, low-frequency ultrasound: the Mayo clinic experience, 2004-2006.
    Kavros SJ; Miller JL; Hanna SW
    Adv Skin Wound Care; 2007 Apr; 20(4):221-6. PubMed ID: 17415030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers.
    Cavorsi J; Vicari F; Wirthlin DJ; Ennis W; Kirsner R; O'Connell SM; Steinberg J; Falanga V
    Wound Repair Regen; 2006; 14(2):102-9. PubMed ID: 16630097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Human amniotic membrane in the management of chronic venous leg ulcers].
    Tauzin H; Humbert P; Viennet C; Saas P; Muret P
    Ann Dermatol Venereol; 2011; 138(8-9):572-9. PubMed ID: 21893230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cell therapy in treatment of trophic ulcers of lower extremities].
    Sedov VM; Andreev DIu; Smirnova TD; Paramonov BA; En'kina TN; Sominina AA; Kiselev OI; Suissi IuIu; Lebedev LV
    Vestn Khir Im I I Grek; 2006; 165(2):90-4. PubMed ID: 16752648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of efficiency of the sonotherapy in enhancement of venous leg ulcer healing in patients after surgical and conservative treatment].
    Franek A; Brzezińska-Wcisło L; Cierpka L; Chmielewska D; Dolibog P; Błaszczak E; Taradaj J
    Pol Merkur Lekarski; 2008 Jul; 25(145):32-7. PubMed ID: 18839611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocyte growth factor may accelerate healing in chronic leg ulcers: a pilot study.
    Nayeri F; Strömberg T; Larsson M; Brudin L; Söderström C; Forsberg P
    J Dermatolog Treat; 2002 Jun; 13(2):81-6. PubMed ID: 12060507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency].
    La Marca G; Pumilia G; Martino A
    Minerva Cardioangiol; 1999 Sep; 47(9):315-9. PubMed ID: 10630070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.